Parvez Fatteh
Physical Medicine & Rehabilitation · San Jose, CANPI 1194774075
Payments from drug & device makers
Across 129 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$452
- Biohaven Pharmaceuticals, Inc.$368
- Collegium Pharmaceutical, Inc.$291
- Daiichi Sankyo Inc.$174
- Redhill Biopharma Inc.$155
- Shionogi Inc$128
- plus $580 from 16 others
What the payments were for
- Food & beverage$2,147100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $452 |
| Biohaven Pharmaceuticals, Inc. | 8 | $368 |
| Collegium Pharmaceutical, Inc. | 25 | $291 |
| Daiichi Sankyo Inc. | 11 | $174 |
| Redhill Biopharma Inc. | 9 | $155 |
| Shionogi Inc | 10 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $99 |
| Forte Bio-pharma LLC | 1 | $77 |
| Boston Scientific | 3 | $72 |
| Scilex Pharmaceuticals Inc. | 4 | $67 |
| Arbor Pharmaceuticals, Inc. | 2 | $33 |
| Pfizer | 2 | $30 |
| Biodelivery Sciences International, Inc. | 2 | $30 |
| MDD US Operations, LLC | 2 | $28 |
| Kaleo, Inc. | 2 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Amgen | 1 | $20 |
| Neuronetics, Inc. | 1 | $18 |
| Novartis | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$246
How this compares
$2,147 in reported general payments places this provider in the 80th percentile of 830 physical medicine & rehabilitation providers in California.
See all physical medicine & rehabilitation providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 216 | $34,528 |
| Doxepin Hcl | 15 | $912 |
| Gabapentin | 36 | $409 |
| Celecoxib | 15 | $293 |
| Ondansetron OdtOndansetron | 31 | $238 |
| Hydroxyzine Pamoate | 14 | $169 |
| Tizanidine Hcl | 11 | $59 |
| Cyclobenzaprine Hcl | 11 | $42 |
| Trazodone Hcl | 13 | $36 |
| Clonidine Hcl | 19 | $12 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USABuprenorphine-Naloxone | $14 | $34,528216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 830 physical medicine & rehabilitation providers in California.
Other physical medicine & rehabilitation in San Jose
- Ziyad AyyoubParamount$1.8M
- John ShenFontana$1.3M
- Andrew SkalskySan Diego$463K
- Nanette JoyceSacramento$237K
- Mary OatesSanta Maria$158K
- Jeryl WiensFresno$125K
- Pratik GandhiAnaheim$122K
- Ronald SchillingLong Beach$113K
- Kevin BarretteSan Francisco$84K
- Jeffrey ChenSan Diego$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.